Octapharma AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Octapharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3434
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy (immune disorders), haematology (coagulation disorders), and critical care therapeutic areas. It sources majority of plasma from company-owned donation centers. Octapharma owns plasma donation centers in the USA and in Germany, and owns six state-of-the-art production facilities in Austria, Germany, France, Mexico and Sweden. The company’s production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labelling, packaging, storage and distribution. Octapharma is headquartered in Lachen, Switzerland.

Octapharma AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Octapharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Octapharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Octapharma AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Octapharma Enters Into Co-Marketing Agreement With Pfizer 10
Licensing Agreements 11
Hikma Pharma Enters into Licensing Agreement with Octapharma 11
Octapharma Enters into Licensing Agreement with Glycotope 12
Equity Offering 13
Glycotope to Raise USD90 Million in Private Placement of Shares 13
Octapharma AG – Key Competitors 14
Octapharma AG – Key Employees 15
Octapharma AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 19
Financial Announcements 19
Mar 01, 2018: Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million 19
Mar 01, 2017: Octapharma Group Publishes 2016 Annual Results Reporting Revenue of €1.6 Billion and Operating Income of €383 Million 20
Product News 21
May 28, 2018: Octapharma present new data on the benefits of Nuwiq in patients with haemophilia A at the World Federation of Hemophilia 2018 World Congress 21
Clinical Trials 22
May 28, 2018: Octapharma share promising preclinical data for SubQ-8, a novel subcutaneous recombinant FVIII, at WFH 2018 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Octapharma AG, Pharmaceuticals & Healthcare, Key Facts 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Octapharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Octapharma AG, Deals By Therapy Area, 2012 to YTD 2018 8
Octapharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Octapharma Enters Into Co-Marketing Agreement With Pfizer 10
Hikma Pharma Enters into Licensing Agreement with Octapharma 11
Octapharma Enters into Licensing Agreement with Glycotope 12
Glycotope to Raise USD90 Million in Private Placement of Shares 13
Octapharma AG, Key Competitors 14
Octapharma AG, Key Employees 15
Octapharma AG, Other Locations 16
Octapharma AG, Subsidiaries 16

List of Figures
Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Octapharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Octapharma AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SeaBird Exploration PLC (SBX)-石油・ガス分野:企業M&A・提携分析
    Summary SeaBird Exploration Ltd (SeaBird) is an oil and gas company that provides marine 2D and 3D seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, …
  • CVS Health Corporation:企業の戦略・SWOT・財務情報
    CVS Health Corporation - Strategy, SWOT and Corporate Finance Report Summary CVS Health Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oil India Ltd (OIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil India Ltd (OIL) is an integrated upstream petroleum company which explores, develops, and produces crude oil and natural gas. It has petroleum exploration licenses in India; and exploration and production blocks across Venezuela, Gabon, Myanmar, Nigeria, Libya, Mozambique, Bangladesh, th …
  • SunTrust Banks Inc:企業の戦略・SWOT・財務情報
    SunTrust Banks Inc - Strategy, SWOT and Corporate Finance Report Summary SunTrust Banks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ambry Genetics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorder …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Duke Energy Corporation (DUK):電力:M&Aディール及び事業提携情報
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • Pembina Pipeline Corp (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Pembina Pipeline Corp (Pembina) is a midstream oil and gas company. It owns and operates an integrated system of pipelines that transports hydrocarbon liquids such as conventional crude oil, heavy oil, synthetic crude oil, and oil sands products. The company offers services such as oil and n …
  • Medicontur Medical Engineering Ltd:製品パイプライン分析
    Summary Medicontur Medical Engineering Ltd (Medicontur) is a developer and manufacturer of intraocular lenses. The company offers hydrophilic and hydrophobic model lenses including monofocal aspheric, toric, and standard monofocal aspheric lenses; preloaded capsular tension rings; PMMA implants; inj …
  • Marriott Vacations Worldwide Corp:企業の戦略・SWOT・財務分析
    Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Strides Pharma Science Ltd (STAR):企業の財務・戦略的SWOT分析
    Summary Strides Pharma Science Ltd (Strides Pharma), formerly Strides Shasun Ltd, develops and manufactures finished dosage formulations and generic pharmaceutical products. The company operates through pharma, branded generic and institutional business segments. It manufactures soft and hard gelati …
  • MYnd Analytics Inc (MYAN)-医療機器分野:企業M&A・提携分析
    Summary MYnd Analytics Inc (MYnd), formerly CNS Response Inc is a biotechnology company that offers medication development programs. The company performs analysis and research, and develops medication for individual patients suffering from mental health and other issues. It provides an PEER Online, …
  • Nippon Kayaku Co., Ltd.:企業の戦略・SWOT・財務情報
    Nippon Kayaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Kayaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • HanAll Biopharma Co Ltd (009420):企業の財務・戦略的SWOT分析
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for trea …
  • General Electric Co (GE)-医療機器分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Compania Logistica de Hidrocarburos CLH SA:企業の戦略的SWOT分析
    Compania Logistica de Hidrocarburos CLH SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Medical Developments International Ltd (MVP):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • Glenmark Pharmaceuticals Ltd (GLENMARK):企業の財務・戦略的SWOT分析
    Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • ERG Renew SpA:企業の戦略的SWOT分析
    ERG Renew SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • JP Elektroprivreda BiH d.d. Sarajevo (JPESR)-エネルギー分野:企業M&A・提携分析
    Summary JP Elektroprivreda BiH d.d. Sarajevo (Elektroprivreda BiH) is a utility company that generates, transmits, supplies, and trades electricity. It also exports and imports electricity, including the management of electricity system. The company generates electricity from coal and hydro sources. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆